TEDIZOLID PHOSPHATE

TEDIZOLID PHOSPHATE was reported 803 times

TEDIZOLID PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR PSEUDOANEURYSM THROMBOSIS 10 0.3704
1 DIABETIC MONONEUROPATHY 1 0.2000
2 PRESBYACUSIS 10 0.0325
3 THORACIC SPINAL STENOSIS 1 0.0238
4 PRODUCT ORIGIN UNKNOWN 1 0.0233
5 CARDIAC VALVE VEGETATION 10 0.0206
6 INTERCOSTAL NEURALGIA 3 0.0169
7 EMBOLIC CEREBRAL INFARCTION 10 0.0151
8 HAEMOPERITONEUM 10 0.0125
9 PERIORBITAL INFECTION 1 0.0123
10 POST INFECTION GLOMERULONEPHRITIS 1 0.0119
11 CAPNOCYTOPHAGA INFECTION 1 0.0106
12 ATYPICAL MYCOBACTERIUM TEST POSITIVE 1 0.0103
13 WOUND DRAINAGE 8 0.0101
14 MYCOBACTERIUM CHELONAE INFECTION 7 0.0095
15 MILLER FISHER SYNDROME 2 0.0089
16 DERMATOPHYTOSIS OF NAIL 1 0.0084
17 GLOMERULAR FILTRATION RATE ABNORMAL 11 0.0078
18 TRICHOGLOSSIA 3 0.0073
19 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
20 GASTROINTESTINAL CANDIDIASIS 3 0.0072
21 ENDOCARDITIS ENTEROCOCCAL 1 0.0070
22 PRODUCT IDENTIFICATION NUMBER ISSUE 1 0.0067
23 MEDICAL DEVICE SITE JOINT INFECTION 1 0.0064
24 POST-TRAUMATIC HEADACHE 1 0.0064
25 PIRIFORMIS SYNDROME 1 0.0059
26 HEPATIC HAEMORRHAGE 5 0.0058
27 SOCIOECONOMIC PRECARITY 1 0.0058
28 POST LAMINECTOMY SYNDROME 1 0.0058
29 COLOUR BLINDNESS ACQUIRED 2 0.0055
30 CALCIUM METABOLISM DISORDER 1 0.0053
31 TOXIC SHOCK SYNDROME STREPTOCOCCAL 1 0.0052
32 CHOLESTATIC LIVER INJURY 11 0.0049
33 MYCOBACTERIUM TEST POSITIVE 1 0.0049
34 GRAM STAIN POSITIVE 1 0.0049
35 TARSAL TUNNEL SYNDROME 1 0.0045
36 NOCARDIOSIS 11 0.0043
37 INJECTION SITE PHLEBITIS 1 0.0043
38 CROSS SENSITIVITY REACTION 4 0.0041
39 ACUTE HIV INFECTION 1 0.0040
40 BRAIN ABSCESS 10 0.0039
41 HYPERTENSIVE CARDIOMYOPATHY 1 0.0036
42 SECONDARY HYPERTENSION 1 0.0035
43 WHITE BLOOD CELL COUNT 1 0.0034
44 BLADDER TAMPONADE 1 0.0033
45 COOMBS DIRECT TEST POSITIVE 1 0.0032
46 VASCULAR PAIN 3 0.0031
47 PERIPHERAL NERVE LESION 1 0.0030
48 CONJUNCTIVITIS BACTERIAL 1 0.0029
49 ABSCESS BACTERIAL 1 0.0028
50 SHOCK SYMPTOM 1 0.0027
51 NASAL TURBINATE HYPERTROPHY 1 0.0027
52 TOXIC NEUROPATHY 1 0.0025
53 INFUSION 1 0.0024
54 TOOTH DISCOLOURATION 7 0.0024
55 BLOOD CREATININE ABNORMAL 8 0.0023
56 HEPATIC LESION 10 0.0023
57 TOXIC OPTIC NEUROPATHY 1 0.0023
58 HYPERLACTACIDAEMIA 6 0.0022
59 PROTEIN-LOSING GASTROENTEROPATHY 1 0.0020
60 RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
61 PLASMAPHERESIS 1 0.0019
62 BURSITIS INFECTIVE 1 0.0018
63 NAIL DYSTROPHY 1 0.0018
64 PLATELET COUNT 1 0.0017
65 SUPERIOR VENA CAVA SYNDROME 1 0.0017
66 CELLULITIS STAPHYLOCOCCAL 1 0.0015
67 BICYTOPENIA 3 0.0015
68 PRODUCT AVAILABILITY ISSUE 33 0.0014
69 SUTURE RUPTURE 1 0.0014
70 PRODUCT DESIGN ISSUE 1 0.0014
71 MYCOBACTERIUM ABSCESSUS INFECTION 1 0.0014
72 BRADYPHRENIA 9 0.0014
73 IMPLANT SITE EXTRAVASATION 1 0.0013
74 PRODUCT SUPPLY ISSUE 9 0.0013
75 INCISION SITE HAEMORRHAGE 1 0.0012
76 SHOCK HAEMORRHAGIC 10 0.0012
77 PULMONARY NOCARDIOSIS 1 0.0012
78 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
79 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
80 OROPHARYNGEAL CANDIDIASIS 1 0.0011
81 MUSCLE NECROSIS 1 0.0011
82 SEROTONIN SYNDROME 21 0.0011
83 CERUMEN IMPACTION 1 0.0011
84 HAEMOPHILUS INFECTION 1 0.0010
85 HEPATIC CYTOLYSIS 13 0.0010
86 RENAL HAEMORRHAGE 2 0.0010
87 ANAEMIA MACROCYTIC 2 0.0009
88 CARDIAC OPERATION 8 0.0009
89 PEPTIC ULCER 3 0.0009
90 PSEUDOMEMBRANOUS COLITIS 2 0.0009
91 INCORRECT PRODUCT ADMINISTRATION DURATION 19 0.0009
92 ARTERIAL HAEMORRHAGE 1 0.0009
93 ACUTE LUNG INJURY 1 0.0008
94 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
95 GLUCOSE URINE PRESENT 1 0.0008
96 CACHEXIA 4 0.0008
97 APLASTIC ANAEMIA 4 0.0008
98 ORGAN FAILURE 3 0.0007
99 CYSTIC FIBROSIS 4 0.0007
100 CATAPLEXY 1 0.0007
101 GENITAL RASH 1 0.0007
102 TOXIC SKIN ERUPTION 7 0.0007
103 VOMITING PROJECTILE 2 0.0007
104 METABOLIC ENCEPHALOPATHY 2 0.0007
105 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
106 DIABETIC FOOT 2 0.0007
107 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
108 EOSINOPHILIC PNEUMONIA 2 0.0006
109 HYPERTENSIVE CRISIS 7 0.0006
110 PANCYTOPENIA 34 0.0006
111 MEDICAL PROCEDURE 1 0.0006
112 NEPHRITIS 2 0.0006
113 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
114 VASCULAR PSEUDOANEURYSM 1 0.0006
115 PURPURA 5 0.0006
116 LUNG TRANSPLANT 2 0.0006
117 THROMBOCYTOPENIA 62 0.0006
118 SOFT TISSUE INFECTION 1 0.0005
119 ESSENTIAL HYPERTENSION 1 0.0005
120 BODY TEMPERATURE ABNORMAL 1 0.0005
121 MECHANICAL VENTILATION 1 0.0005
122 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
123 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
124 PROCEDURAL HAEMORRHAGE 2 0.0005
125 HYPOGEUSIA 1 0.0005
126 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
127 PRODUCT PRESCRIBING ISSUE 11 0.0005
128 MYOCLONUS 6 0.0005
129 NIPPLE PAIN 1 0.0005
130 PANCREATITIS ACUTE 11 0.0005
131 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
132 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
133 OPTIC NEUROPATHY 1 0.0005
134 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
135 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
136 DENTAL CARIES 5 0.0005
137 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
138 TONGUE BLISTERING 1 0.0004
139 SYNOVIAL CYST 2 0.0004
140 ARTHRITIS INFECTIVE 2 0.0004
141 HYPOMAGNESAEMIA 6 0.0004
142 BILIRUBIN CONJUGATED INCREASED 1 0.0004
143 VARICELLA 1 0.0004
144 OXYGEN CONSUMPTION INCREASED 1 0.0004
145 ENTEROCOCCAL INFECTION 2 0.0004
146 GASTROINTESTINAL TUBE INSERTION 1 0.0004
147 EOSINOPHILIA 7 0.0004
148 PHLEBITIS 2 0.0004
149 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
150 WHITE BLOOD CELL DISORDER 1 0.0004
151 EAR CONGESTION 1 0.0004
152 LARGE INTESTINAL ULCER 1 0.0004
153 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
154 LIP BLISTER 1 0.0004
155 ORAL FUNGAL INFECTION 1 0.0004
156 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
157 INTRACRANIAL PRESSURE INCREASED 2 0.0004
158 PRODUCT USE IN UNAPPROVED INDICATION 88 0.0004
159 HEPATOCELLULAR INJURY 5 0.0004
160 ADENOVIRUS INFECTION 1 0.0003
161 LUMBAR SPINAL STENOSIS 1 0.0003
162 NECK INJURY 1 0.0003
163 CATARACT OPERATION 2 0.0003
164 MIXED LIVER INJURY 1 0.0003
165 CENTRAL VENOUS CATHETERISATION 1 0.0003
166 OPTIC NEURITIS 3 0.0003
167 MASTICATION DISORDER 1 0.0003
168 TINNITUS 15 0.0003
169 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
170 MULTIPLE-DRUG RESISTANCE 1 0.0003
171 CHOLESTASIS 6 0.0003
172 ROTATOR CUFF SYNDROME 4 0.0003
173 BACTERIAL SEPSIS 1 0.0003
174 INABILITY TO AFFORD MEDICATION 3 0.0003
175 CARDIAC FAILURE ACUTE 2 0.0003
176 POTENTIATING DRUG INTERACTION 1 0.0003
177 WOUND DEHISCENCE 1 0.0003
178 EAR DISCOMFORT 3 0.0003
179 WOUND COMPLICATION 1 0.0003
180 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
181 ERYTHEMA NODOSUM 1 0.0003
182 MACULOPATHY 1 0.0003
183 OSTEOMYELITIS 5 0.0003
184 ANAEMIA 51 0.0003
185 THROAT CLEARING 1 0.0003
186 REHABILITATION THERAPY 1 0.0003
187 WOUND SECRETION 1 0.0003
188 SKIN PAPILLOMA 1 0.0002
189 BLEPHARITIS 1 0.0002
190 CYSTITIS HAEMORRHAGIC 1 0.0002
191 LACTIC ACIDOSIS 8 0.0002
192 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
193 LEG AMPUTATION 1 0.0002
194 AORTIC DISSECTION 1 0.0002
195 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
196 NO ADVERSE EVENT 43 0.0002
197 MUSCLE FATIGUE 1 0.0002
198 AORTIC VALVE INCOMPETENCE 1 0.0002
199 HEPATITIS 6 0.0002
200 INTERVERTEBRAL DISC DISORDER 1 0.0002
201 PURULENT DISCHARGE 1 0.0002
202 PULMONARY FUNCTION TEST DECREASED 1 0.0002
203 PARONYCHIA 1 0.0002
204 IMMUNOSUPPRESSION 2 0.0002
205 LIGAMENT RUPTURE 1 0.0002
206 BLOOD CREATINE INCREASED 1 0.0002
207 SUSPECTED OFF LABEL USE 1 0.0002
208 PATHOGEN RESISTANCE 2 0.0002
209 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
210 HAEMOGLOBIN INCREASED 1 0.0002
211 DISEASE COMPLICATION 1 0.0002
212 AGRANULOCYTOSIS 4 0.0002
213 ROSACEA 1 0.0002
214 STAPHYLOCOCCAL INFECTION 7 0.0002
215 HUMERUS FRACTURE 1 0.0002
216 PANCREATIC DISORDER 1 0.0002
217 STAPHYLOCOCCAL SEPSIS 1 0.0002
218 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
219 IMMUNODEFICIENCY 3 0.0002
220 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
221 HEPATIC ENZYME ABNORMAL 1 0.0002
222 NEUROPATHY PERIPHERAL 19 0.0002
223 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
224 TOOTH ABSCESS 2 0.0002
225 FAILURE TO THRIVE 1 0.0002
226 BLOOD LACTIC ACID INCREASED 1 0.0002
227 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
228 TRANSAMINASES INCREASED 4 0.0002
229 NECROSIS 1 0.0002
230 ACUTE PULMONARY OEDEMA 1 0.0002
231 ADVERSE EVENT 16 0.0002
232 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
233 HYPERTRIGLYCERIDAEMIA 1 0.0002
234 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
235 BACTERAEMIA 2 0.0002
236 BLOOD CREATININE INCREASED 11 0.0002
237 RHABDOMYOLYSIS 7 0.0002
238 HEPATITIS CHOLESTATIC 1 0.0002
239 BURSITIS 2 0.0002
240 MENISCUS INJURY 1 0.0002
241 INFUSION SITE EXTRAVASATION 1 0.0002
242 SECRETION DISCHARGE 2 0.0002
243 CELLULITIS 8 0.0002
244 ENTERITIS 1 0.0002
245 PLATELET COUNT INCREASED 2 0.0002
246 PRODUCT PREPARATION ISSUE 1 0.0002
247 HYPOGAMMAGLOBULINAEMIA 1 0.0002
248 DYSGRAPHIA 1 0.0002
249 APPETITE DISORDER 1 0.0002
250 VISUAL ACUITY REDUCED 5 0.0002
251 LIMB INJURY 4 0.0001
252 JOINT EFFUSION 1 0.0001
253 PROCEDURAL PAIN 4 0.0001
254 PAPULE 1 0.0001
255 PULMONARY TOXICITY 1 0.0001
256 LYMPHOPENIA 2 0.0001
257 HAND FRACTURE 1 0.0001
258 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
259 PANIC REACTION 1 0.0001
260 MAJOR DEPRESSION 1 0.0001
261 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
262 FEELING DRUNK 1 0.0001
263 PAROSMIA 1 0.0001
264 HEPATOCELLULAR CARCINOMA 1 0.0001
265 TROPONIN INCREASED 1 0.0001
266 INSURANCE ISSUE 2 0.0001
267 ANKLE FRACTURE 2 0.0001
268 CONCUSSION 1 0.0001
269 HYPOALBUMINAEMIA 1 0.0001
270 OFF LABEL USE 110 0.0001
271 BLOOD DISORDER 1 0.0001
272 FRUSTRATION TOLERANCE DECREASED 1 0.0001
273 PRESYNCOPE 3 0.0001
274 POST PROCEDURAL INFECTION 1 0.0001
275 DECUBITUS ULCER 1 0.0001
276 PLATELET COUNT DECREASED 13 0.0001
277 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
278 SPINAL COMPRESSION FRACTURE 1 0.0001
279 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
280 BLOOD UREA INCREASED 2 0.0001
281 HAEMODIALYSIS 1 0.0001
282 CANDIDA INFECTION 2 0.0001
283 ACUTE KIDNEY INJURY 18 0.0001
284 MUSCLE STRAIN 1 0.0001
285 BLOOD CALCIUM INCREASED 1 0.0001
286 HEAD DISCOMFORT 2 0.0001
287 MYELOSUPPRESSION 4 0.0001
288 LEUKOCYTOSIS 2 0.0001
289 NEUTROPENIA 15 0.0001
290 SKIN LESION 3 0.0001
291 PRODUCT DOSE OMISSION ISSUE 32 0.0001
292 PRODUCT DISTRIBUTION ISSUE 1 0.0001
293 BACTERIAL INFECTION 2 0.0001
294 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
295 PULMONARY EMBOLISM 10 0.0001
296 AUTOIMMUNE DISORDER 1 0.0001
297 VITAMIN D DEFICIENCY 1 0.0001
298 INFLAMMATORY BOWEL DISEASE 1 0.0001
299 PHARYNGEAL SWELLING 1 0.0001
300 HAEMATOCRIT DECREASED 2 0.0001
301 HEPATIC FAILURE 3 0.0001
302 VERTIGO 6 0.0001
303 EPILEPSY 3 0.0001
304 MOTOR DYSFUNCTION 1 0.0001
305 TEMPERATURE INTOLERANCE 1 0.0001
306 HYPERBILIRUBINAEMIA 1 0.0001
307 DRUG INTERACTION 15 0.0001
308 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
309 BRADYCARDIA 5 0.0001
310 POOR QUALITY SLEEP 2 0.0001
311 IMPAIRED HEALING 3 0.0001
312 WOUND INFECTION 1 0.0001
313 ASPIRATION 1 0.0001
314 HOSPITALISATION 14 0.0001
315 MELAENA 2 0.0001
316 SKIN INFECTION 1 0.0001
317 NEPHROPATHY TOXIC 1 0.0001
318 BLOOD CALCIUM DECREASED 1 0.0001
319 CHROMATURIA 2 0.0001
320 ELECTROLYTE IMBALANCE 1 0.0001
321 DYSPHONIA 5 0.0001
322 MUSCLE RIGIDITY 1 0.0001
323 WRIST FRACTURE 1 0.0001
324 DRUG INTOLERANCE 8 0.0001
325 LOCALISED INFECTION 2 0.0001
326 PARAESTHESIA 13 0.0001
327 CYTOPENIA 1 0.0001
328 ENCEPHALOPATHY 2 0.0001
329 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
330 SMALL INTESTINAL OBSTRUCTION 1 0.0001
331 TENDON RUPTURE 1 0.0001
332 DYSGEUSIA 6 0.0001
333 CYST 1 0.0001
334 HEPATIC FUNCTION ABNORMAL 3 0.0001
335 HAIR COLOUR CHANGES 1 0.0001
336 PRODUCT USE ISSUE 15 0.0001
337 DYSPNOEA EXERTIONAL 3 0.0001
338 DRUG RESISTANCE 2 0.0001
339 HAND DEFORMITY 1 0.0001
340 QUALITY OF LIFE DECREASED 1 0.0001
341 SINUS CONGESTION 1 0.0001
342 HAEMATOCHEZIA 4 0.0001
343 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
344 SEPSIS 8 0.0001
345 HAEMOPTYSIS 2 0.0001
346 CARPAL TUNNEL SYNDROME 1 0.0001
347 BLINDNESS UNILATERAL 1 0.0001
348 SINUS TACHYCARDIA 1 0.0001
349 BRONCHOSPASM 1 0.0001
350 SEPTIC SHOCK 3 0.0001
351 HAEMOGLOBIN DECREASED 7 0.0001
352 COLON CANCER 1 0.0001
353 THROAT IRRITATION 3 0.0001
354 ILL-DEFINED DISORDER 4 0.0001
355 NEPHROLITHIASIS 3 0.0001
356 FEELING HOT 4 0.0001
357 PHARYNGEAL OEDEMA 1 0.0001
358 DELUSION 1 0.0001
359 ACUTE MYELOID LEUKAEMIA 1 0.0001
360 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
361 PNEUMOTHORAX 1 0.0001
362 RESPIRATORY TRACT CONGESTION 1 0.0001
363 SCIATICA 1 0.0001
364 ABSCESS 1 0.0001
365 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
366 HYPERHIDROSIS 8 0.0001
367 PRODUCT DOSE OMISSION 4 0.0001
368 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
369 RENAL IMPAIRMENT 5 0.0001
370 FACE OEDEMA 1 0.0001
371 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
372 HAEMATURIA 2 0.0001
373 VISION BLURRED 8 0.0001
374 PARANOIA 1 0.0001
375 GAIT DISTURBANCE 11 0.0001
376 ORTHOSTATIC HYPOTENSION 1 0.0001
377 RASH 25 0.0001
378 NAUSEA 45 0.0001
379 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
380 DRUG ERUPTION 1 0.0001
381 PELVIC PAIN 1 0.0001
382 HYPERGLYCAEMIA 2 0.0001
383 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
384 BLOOD GLUCOSE ABNORMAL 1 0.0001
385 CONJUNCTIVITIS 1 0.0001
386 MIDDLE INSOMNIA 1 0.0001
387 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
388 BLOOD URINE PRESENT 1 0.0001
389 FEELING JITTERY 1 0.0001
390 DYSTONIA 1 0.0001
391 CATARACT 3 0.0001
392 TASTE DISORDER 1 0.0000
393 BONE MARROW FAILURE 1 0.0000
394 NEUTROPHIL COUNT DECREASED 2 0.0000
395 ILLNESS 5 0.0000
396 FALL 16 0.0000
397 KNEE ARTHROPLASTY 1 0.0000
398 HALLUCINATION, VISUAL 1 0.0000
399 HYPOACUSIS 2 0.0000
400 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
401 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
402 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
403 STEVENS-JOHNSON SYNDROME 1 0.0000
404 VOMITING 21 0.0000
405 ORAL PAIN 1 0.0000
406 HEPATIC ENZYME INCREASED 3 0.0000
407 THERAPY INTERRUPTED 3 0.0000
408 DIARRHOEA 27 0.0000
409 URTICARIA 7 0.0000
410 ABDOMINAL DISCOMFORT 7 0.0000
411 DIABETIC KETOACIDOSIS 1 0.0000
412 HEPATIC CANCER 1 0.0000
413 INTERSTITIAL LUNG DISEASE 2 0.0000
414 HYPOGLYCAEMIA 2 0.0000
415 LIVER INJURY 1 0.0000
416 AGEUSIA 1 0.0000
417 CONDITION AGGRAVATED 12 0.0000
418 ERYTHEMA 8 0.0000
419 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
420 RASH GENERALISED 1 0.0000
421 DEAFNESS 1 0.0000
422 MUCOSAL INFLAMMATION 1 0.0000
423 ANHEDONIA 1 0.0000
424 JAUNDICE 1 0.0000
425 RASH PRURITIC 2 0.0000
426 PNEUMONITIS 1 0.0000
427 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
428 ANAPHYLACTIC REACTION 2 0.0000
429 DIVERTICULITIS 1 0.0000
430 MENTAL STATUS CHANGES 1 0.0000
431 NECK PAIN 2 0.0000
432 DEMENTIA 1 0.0000
433 HYPONATRAEMIA 2 0.0000
434 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
435 INFECTION 5 0.0000
436 DECREASED APPETITE 8 0.0000
437 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
438 SURGERY 2 0.0000
439 ABDOMINAL PAIN UPPER 7 0.0000
440 PRURITUS 13 0.0000
441 RESPIRATORY DISORDER 1 0.0000
442 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
443 DRUG ADMINISTRATION ERROR 1 0.0000
444 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
445 PERIPHERAL SWELLING 5 0.0000
446 FEMUR FRACTURE 1 0.0000
447 WEIGHT DECREASED 9 0.0000
448 SWOLLEN TONGUE 1 0.0000
449 DRUG-INDUCED LIVER INJURY 1 0.0000
450 MIGRAINE 3 0.0000
451 NIGHT SWEATS 1 0.0000
452 SWELLING FACE 2 0.0000
453 EYE DISORDER 1 0.0000
454 TREMOR 5 0.0000
455 EXPIRED PRODUCT ADMINISTERED 1 0.0000
456 VIRAL INFECTION 1 0.0000
457 DYSPNOEA 17 0.0000
458 FUNGAL INFECTION 1 0.0000
459 GAIT INABILITY 1 0.0000
460 TYPE 2 DIABETES MELLITUS 1 0.0000
461 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
462 RASH MACULAR 1 0.0000
463 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
464 CEREBRAL HAEMORRHAGE 1 0.0000
465 DRUG EFFECT INCOMPLETE 1 0.0000
466 DRUG INEFFECTIVE 36 0.0000
467 ASTHMA 3 0.0000
468 INTESTINAL OBSTRUCTION 1 0.0000
469 UNEVALUABLE EVENT 2 0.0000
470 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
471 COUGH 7 0.0000
472 PNEUMONIA 8 0.0000
473 BLINDNESS 1 0.0000
474 DIZZINESS 12 0.0000
475 HEADACHE 15 0.0000
476 SKIN EXFOLIATION 2 0.0000
477 OSTEOARTHRITIS 1 0.0000
478 URINARY TRACT INFECTION 4 0.0000
479 BALANCE DISORDER 2 0.0000
480 DEVICE LEAKAGE 1 0.0000
481 ANGIOEDEMA 1 0.0000
482 TACHYCARDIA 2 0.0000
483 DEHYDRATION 3 0.0000
484 PULMONARY OEDEMA 1 0.0000
485 GASTROINTESTINAL DISORDER 2 0.0000
486 PRODUCT QUALITY ISSUE 3 0.0000
487 DEATH 19 0.0000
488 INCORRECT DOSE ADMINISTERED 5 0.0000
489 FATIGUE 17 0.0000
490 SKIN DISCOLOURATION 1 0.0000
491 HYPOKALAEMIA 1 0.0000
492 OROPHARYNGEAL PAIN 2 0.0000
493 CHEST PAIN 4 0.0000
494 ABDOMINAL PAIN 5 0.0000
495 SWELLING 2 0.0000
496 ASTHENIA 8 0.0000
497 ANXIETY 6 0.0000
498 DISEASE RECURRENCE 1 0.0000
499 COMA 1 0.0000
500 PRODUCTIVE COUGH 1 0.0000
501 RASH ERYTHEMATOUS 1 0.0000
502 MULTIPLE SCLEROSIS 1 0.0000
503 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
504 ATRIAL FIBRILLATION 2 0.0000
505 DYSPEPSIA 2 0.0000
506 PYREXIA 7 0.0000
507 HYPOAESTHESIA 3 0.0000
508 LEUKOPENIA 1 0.0000
509 SYNCOPE 2 0.0000
510 THERAPY CESSATION 1 0.0000
511 HAEMORRHAGE 2 0.0000
512 MUSCULOSKELETAL PAIN 1 0.0000
513 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
514 OEDEMA 1 0.0000
515 CONSTIPATION 4 0.0000
516 TREATMENT NONCOMPLIANCE 1 0.0000
517 OXYGEN SATURATION DECREASED 1 0.0000
518 MYALGIA 3 0.0000
519 BACK PAIN 4 0.0000
520 MYOCARDIAL INFARCTION 3 0.0000
521 PALPITATIONS 2 0.0000
522 BONE PAIN 1 0.0000
523 CHILLS 2 0.0000
524 NASAL CONGESTION 1 0.0000
525 JOINT SWELLING 2 0.0000
526 THERAPEUTIC RESPONSE DECREASED 1 0.0000
527 STOMATITIS 1 0.0000
528 DISCOMFORT 1 0.0000
529 VISUAL IMPAIRMENT 2 0.0000
530 BLOOD GLUCOSE INCREASED 3 0.0000
531 LOSS OF CONSCIOUSNESS 2 0.0000
532 RHINORRHOEA 1 0.0000
533 AMNESIA 1 0.0000
534 INFUSION RELATED REACTION 1 0.0000
535 FEBRILE NEUTROPENIA 1 0.0000
536 RENAL FAILURE 2 0.0000
537 BLOOD PRESSURE DECREASED 1 0.0000
538 NEOPLASM MALIGNANT 1 0.0000
539 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
540 RESPIRATORY FAILURE 1 0.0000
541 AGITATION 1 0.0000
542 EPISTAXIS 1 0.0000
543 HALLUCINATION 1 0.0000
544 CHRONIC KIDNEY DISEASE 1 0.0000
545 FEELING ABNORMAL 3 0.0000
546 THROMBOSIS 1 0.0000
547 DRY MOUTH 1 0.0000
548 INFLUENZA LIKE ILLNESS 1 0.0000
549 CARDIAC ARREST 1 0.0000
550 CEREBROVASCULAR ACCIDENT 2 0.0000
551 MALAISE 5 0.0000
552 COVID-19 2 0.0000
553 PAIN 7 0.0000
554 ADVERSE DRUG REACTION 1 0.0000
555 SUICIDAL IDEATION 1 0.0000
556 HYPERSENSITIVITY 2 0.0000
557 CONTUSION 1 0.0000
558 FLUSHING 1 0.0000
559 CHEST DISCOMFORT 1 0.0000
560 OVERDOSE 2 0.0000
561 MUSCULAR WEAKNESS 1 0.0000
562 DEPRESSION 2 0.0000
563 SEIZURE 1 0.0000
564 DISEASE PROGRESSION 1 0.0000
565 EMOTIONAL DISTRESS 1 0.0000
566 DRY SKIN 1 0.0000
567 ARTHRALGIA 3 0.0000
568 PAIN IN EXTREMITY 2 0.0000
569 BLOOD PRESSURE INCREASED 1 0.0000
570 CONFUSIONAL STATE 1 0.0000
571 DRUG DOSE OMISSION 1 0.0000
572 MUSCLE SPASMS 1 0.0000
573 NASOPHARYNGITIS 1 0.0000
574 ALOPECIA 1 0.0000
575 SOMNOLENCE 1 0.0000
576 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
577 HYPERTENSION 1 0.0000
578 INSOMNIA 1 0.0000